CSIMarket
 


Instil Bio Inc   (TIL)
Other Ticker:  
 
 

TIL's Operating Income Growth by Quarter and Year

Instil Bio Inc 's Operating Income results by quarter and year




TIL Operating Income (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - -16.41 -53.75 -1.17
III Quarter September -66.72 -56.65 -43.02 -1.00
II Quarter June -20.99 -58.72 -35.38 -1.13
I Quarter March -58.45 -54.29 -23.40 0.19
FY   -146.16 -186.07 -155.55 -3.11



TIL Operating Income third quarter 2023 Y/Y Growth Comment
Instil Bio Inc in the third quarter 2023 recorded Operating Loss of $ -66.72 millions.

According to the results reported in the third quarter 2023, Instil Bio Inc achieved the best Operating Income growth in Biotechnology & Pharmaceuticals industry. While Instil Bio Inc ' s Operating Income no change of % ranks overall at the positon no. in the third quarter 2023.

Explain Operating Income growth


TIL Operating Income ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Instil Bio Inc 's third quarter 2023 Operating Income $ -66.72 millions TIL's Income Statement
Instil Bio Inc 's third quarter 2022 Operating Income $ -56.65 millions Quarterly TIL's Income Statement
New: More TIL's historic Operating Income Growth >>


TIL Operating Income (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Instil Bio Inc 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


TIL's III. Quarter Q/Q Operating Income Comment
Recent Operating Loss of -66.72 millions by Instil Bio Inc come out even worse if you take a look at -20.99 millions Operating Loss in the second quarter.

Within Biotechnology & Pharmaceuticals industry Instil Bio Inc achieved highest sequential Operating Income growth. While Instil Bio Inc 's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


TIL's III. Quarter Q/Q Operating Income Comment
Current results of -66.72 millions by Instil Bio Inc appear even more unfavourable if you take a look at -20.99 millions Operating Loss in the second quarter.

Within Biotechnology & Pharmaceuticals industry Instil Bio Inc achieved highest sequential Operating Income growth. While Instil Bio Inc 's Operating Income growth quarter on quarter, overall rank is .


Instil Bio Inc 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Operating Income 12 Months Ending $ -162.56 $ -152.49 $ -190.23 $ -186.07 $ -223.41
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment


Instil Bio Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment


Instil Bio Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Biotechnology & Pharmaceuticals Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
TIL's Operating Income Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for TIL's Competitors
Operating Income Growth for Instil Bio Inc 's Suppliers
Operating Income Growth for TIL's Customers

You may also want to know
TIL's Annual Growth Rates TIL's Profitability Ratios TIL's Asset Turnover Ratio TIL's Dividend Growth
TIL's Roe TIL's Valuation Ratios TIL's Financial Strength Ratios TIL's Dividend Payout Ratio
TIL's Roa TIL's Inventory Turnover Ratio TIL's Growth Rates TIL's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Sep 30 2023
Lantheus Holdings Inc 31.04%$ 31.044 millions
Addus Homecare Corporation30.39%$ 30.389 millions
Third Harmonic Bio Inc 26.30%$ 26.304 millions
Becton Dickinson And Company25.54%$ 25.540 millions
Conmed Corporation24.96%$ 24.959 millions
Sotera Health Company20.42%$ 20.418 millions
Biomx Inc 19.03%$ 19.026 millions
Shockwave Medical Inc 18.66%$ 18.660 millions
Intuitive Surgical Inc 16.77%$ 16.771 millions
Nature s Sunshine Products inc 16.36%$ 16.361 millions
Align Technology inc 15.79%$ 15.795 millions
Stryker Corp15.22%$ 15.223 millions
Encompass Health Corporation14.02%$ 14.021 millions
Idexx Laboratories Inc12.44%$ 12.439 millions
Envista Holdings Corporation11.81%$ 11.812 millions
Surgery Partners Inc 11.47%$ 11.471 millions
Medpace Holdings Inc 9.10%$ 9.098 millions
Zoetis Inc 9.07%$ 9.066 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com